BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin.

Zheng, Yi-Hu

BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin. [electronic resource] - Liver international : official journal of the International Association for the Study of the Liver 12 2016 - 1836-1847 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1478-3231

10.1111/liv.13178 doi


Animals
Antineoplastic Agents--pharmacology
Carcinoma, Hepatocellular--drug therapy
Cell Cycle--drug effects
Cell Proliferation--drug effects
China
Cisplatin--pharmacology
Disease Models, Animal
Drug Resistance, Neoplasm
Female
Gene Expression Regulation, Neoplastic
Hep G2 Cells
Humans
Liver Neoplasms--drug therapy
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Middle Aged
Prognosis
Proto-Oncogene Proteins c-myc--genetics
RNA, Small Interfering--genetics
Transaminases--genetics
Xenograft Model Antitumor Assays